Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-10

FDA Approved: ENTECAVIR — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's supplemental application to market entecavir (ENTECAVIR) as a generic, expanding access for treatment of chronic hepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)